the cliff
Patent cliff
Drugs ranked by the soonest barrier to generic / biosimilar entry. Each row shows the earliest-expiring patent OR FDA exclusivity for that drug — whichever falls first determines when competitive pressure begins.
- Nov 23, 20293.4ypatentOndansetronondansetronIpca Pharmaceuticals Inc
- Dec 13, 20293.4yNCECrenessitycrinecerfont$NBIXNEUROCRINE BIOSCIENCES INC
- Dec 16, 20293.4ypatentGiaprezaangiotensin II acetateLa Jolla Pharmaceutical Company
- Dec 22, 20293.5ypatentGimotimetoclopramide hydrochlorideEvoke Pharma Inc
- Jan 30, 20303.6yNCEJournavxsuzetrigine$VERXVertex, Inc.
- Feb 8, 20303.6ypatentDrospirenone + Ethinyl Estradiol + Levomefolate Calcium(drospirenone + ethinylestradiol + levomefolate calcium) + levomefolate calciumAllergan Sales LLC
- Feb 8, 20303.6ypatentSlynddrospirenoneExeltis USA Inc
- Feb 10, 20303.6ypatentNithiodote(sodium nitrite + sodium thiosulfate)Hope Biosciences LLC
- Feb 10, 20303.6ypatentSodium Nitritesodium nitriteHope Biosciences LLC
- Feb 11, 20303.6ypatentCETIRIZINE HYDROCHLORIDECETIRIZINE HYDROCHLORIDEPL Developments Copiague LLC
- Feb 11, 20303.6yNCEGomeklimirdametinibSpringWorks Therapeutics Inc
- Feb 12, 20303.6ypatentALVIMOPANALVIMOPANPar Pharmaceutical Inc
- Feb 14, 20303.6yNCERomvimzavimseltinibOno Pharmaceutical Co Ltd
- Feb 24, 20303.6ypatentTAZAROTENETAZAROTENE$GRIGRI Bio, Inc.
- Mar 11, 20303.7ypatentIDELALISIBIDELALISIB$GILDGILEAD SCIENCES, INC.
- Mar 24, 20303.7ypatentOtovel(ciprofloxacin hydrochloride + fluocinolone acetonide)SALVAT USA Inc
- Mar 28, 20303.7yNCEQfitliafitusiran [INN]Genzyme Corp
- Apr 2, 20303.7ypatentKovanaze(oxymetazoline hydrochloride + tetracaine hydrochloride)St Renatus LLC
- Apr 9, 20303.7ypatentBRIVARACETAMBRIVARACETAMUCB SA
- Apr 17, 20303.8ypatentTICAGRELORTICAGRELORHisun Pharmaceutical USA Inc
- Apr 19, 20303.8ypatentCelecoxib GreenstonecelecoxibGreenstone LLC
- Apr 23, 20303.8ypatentLicartdiclofenacIBSA Pharma Inc
- Apr 23, 20303.8ypatentIndomethacinindomethacinACP Nimble Buyer Inc
- May 26, 20303.9ypatentQamzovameloxicamNanjing Delova Biotech Co Ltd
- May 26, 20303.9ypatentVenclextavenetoclax$ABBVAbbVie Inc.
- May 28, 20303.9ypatentSymbicort Aerosphere(budesonide + formoterol fumarate)AstraZeneca Pharmaceuticals LP
- May 28, 20303.9ypatentBevespi Aerosphere(formoterol fumarate + glycopyrrolate)AstraZeneca Pharmaceuticals LP
- May 28, 20303.9yNCETryptyracoltremon$ALCALCON INC
- Jun 2, 20303.9ypatentStivargaregorafenibBayer AG
- Jun 7, 20303.9ypatentParlodelbromocriptine mesylateValidus Pharmaceuticals LLC
- Jun 11, 20303.9yNCEIbtrozitaletrectinib adipate$NUVBNuvation Bio Inc.
- Jun 16, 20303.9ypatentSumatriptansumatriptan [INN]Florida Pharmaceutical Products LLC
- Jun 17, 20303.9ypatentSimbrinza(brimonidine tartrate + brinzolamide)$NVSNOVARTIS AG
- Jun 21, 20303.9ypatentIdhifaenasidenib mesylateBristol-Myers Squibb Co
- Jun 24, 20304.0ypatentAristadaaripiprazole lauroxilAlkermes US Holdings Inc
- Jul 2, 20304.0yNCEZegfrovysunvozertinibDizal Pharmaceutical Co Ltd
- Jul 3, 20304.0yNCEEkterlysebetralstat [INN]$KALVKalVista Pharmaceuticals, Inc.
- Jul 13, 20304.0ypatentSegluromet(ertugliflozin + metformin hydrochloride)$MRKMerck & Co., Inc.
- Jul 13, 20304.0ypatentERTUGLIFLOZINERTUGLIFLOZIN$MRKMerck & Co., Inc.
- Jul 21, 20304.0ypatentAuryxiaferric citrate$AKBAAkebia Therapeutics, Inc.
- Jul 23, 20304.0yNCEAnzupgodelgocitinibLeo Pharma AS
- Jul 28, 20304.1ypatentXospatagilteritinib fumarateAstellas Pharma US Inc
- Jul 28, 20304.1yNCESephiencesepiapterin$PTCPTC INC.
- Jul 29, 20304.1ypatentParsabivetelcalcetide hydrochloride$AMGNAMGEN INC
- Jul 31, 20304.1yNCEVizzaceclidine$LENZLENZ Therapeutics, Inc.
- Aug 2, 20304.1ypatentAllegrafexofenadine hydrochlorideChattem Inc
- Aug 6, 20304.1yNCEModeysodordaviprone hydrochloride$JAZZJazz Pharmaceuticals plc
- Aug 12, 20304.1yNCEBrinsupribrensocatib$INSMINSMED Inc
- Aug 28, 20304.1ypatentBrexafemmeibrexafungerp citrate$GSKGSK plc
- Aug 29, 20304.1yNCEWayrilzrilzabrutinib$SNYSanofi
sourced from FDA Orange Book · approved drugs only · biologics + biosimilars excluded (those live in the Purple Book — coming soon)